Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients with Interstitial Lung Disease

Document text

Principal Investigator: Leighton  Chan
Organization: CLINICAL CENTER
Fiscal Year: 2024
Funding agency: NIH Clinical Center

AET is generally safe, inexpensive, and can easily be made available and accessible to almost everyone. It requires no approval by regulatory agencies and is thus available as a medically prescribed and supervised intervention almost immediately following confirmation of its safety and efficacy. Six-minute walk distance is associated with improved HRQoL in patients with ILD and in specific subsets. Effective use of AET as a rehabilitative intervention could have a high degree of impact on personal and public health outcomes in this advanced lung disease subset.

Total Number of Subjects Screened= 175 (over the life of the protocol)
Total Number of Subjects Enrolled = 46

This study was closed to recruitment in May 2023 and continues in data analysis. Our ability to recruit and enroll participants were hampered by competition from drug trials and suspension of research activities during the COVID-19 pandemic. Several safety and scientific reasons also affected re-opening of this study, mainly the exposure of COVID-19 in patients with pulmonary compromise.

In FY22, we reported results from this study to the clinicaltrials.gov (CT.gov) registry. Other data analysis and manuscript preparations are in progress and will be forthcoming.

Terms: <Aerobic><Aerobic Activity><Aerobic Exercise><Aerobic Training><Aerobic fitness><Affect><Behavioral><COPD><COVID crisis><COVID epidemic><COVID pandemic><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 exposure><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 years><Causality><Cell Respiration><Cellular Respiration><Chronic Obstruction Pulmonary Disease><Chronic Obstructive Lung Disease><Chronic Obstructive Pulmonary Disease><Data><Data Analyses><Data Analysis><Drugs><Energy Expenditure><Energy Metabolism><Enrollment><Etiology><Exercise><Exercise Test><Exercise Therapy><Exercise based rehabilitation><Fatigue><Guidelines><Health Status><Health Surveys><Human Activities><Interstitial Lung Diseases><Intervention><Intervention Strategies><Lack of Energy><Level of Health><Life><Lung><Lung Diseases><Lung Respiratory System><Manuscripts><Measures><Medical><Medical Rehabilitation><Medication><Metabolic><Modality><Moods><Muscle><Muscle Tissue><Outcome><Outcome Measure><Patient Care><Patient Care Delivery><Patients><Pharmaceutical Preparations><Physical activity><Preparation><Protocol><Protocols documentation><Public Health><Pulmonary Diseases><Pulmonary Disorder><Pulmonary Gas Exchange><Pulmonary Hypertension><Questionnaires><Regimen><Registries><Rehabilitation><Rehabilitation therapy><Reporting><Research><Research Activity><SARS-CoV-2 epidemic><SARS-CoV-2 exposure><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-CoV2 exposure><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><Safety><Serious Adverse Event><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Adverse Event><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 exposure><Severe acute respiratory syndrome coronavirus 2 pandemic><Severities><Suspension substance><Suspensions><Symptoms><Test Result><Testing><Therapeutic exercise><Time><Training><Training Programs><Uncontrolled Study><Walking><Work><aerobic metabolism><aerobic respiration><care for patients><care of patients><caring for patients><causation><chronic obstructive pulmonary disorder><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 exposure><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><data interpretation><determine efficacy><disease causation><disease of the lung><disorder of the lung><drug/agent><efficacy analysis><efficacy assessment><efficacy determination><efficacy evaluation><efficacy examination><enroll><evaluate efficacy><examine efficacy><exercise rehabilitation><exercise training><exercise treatment><exposure to COVID-19><exposure to SARS-CoV-2><exposure to SARS-CoV2><exposure to Severe acute respiratory syndrome coronavirus 2><exposure to coronavirus disease 2019><health level><health related quality of life><improved><indexing><interventional strategy><lung disorder><lung rehabilitation><measurable outcome><muscular><outcome measurement><oxidative metabolism><participant enrollment><patient enrollment><patient safety><preparations><primary outcome><psychosocial><pulmonary><pulmonary rehabilitation><recruit><rehab therapy><rehabilitative><rehabilitative exercise><rehabilitative therapy><respiratory><response><secondary outcome><serious adverse experience><serious adverse reaction><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><standard of care><treadmill><treated with exercise>